MTS Atlas
← All investors
F

Firm & fund profile / Sourced portfolio

F-Prime

Tracked participation in 2 Atlas companies, with 0 explicitly attributed leads.

2portfolio companies
2round participations
0lead positions
Apr 2024latest activity
Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner
Xaira Therapeutics—Apr 2024 → Apr 20241 roundParticipant—
Owkin—— → —1 roundParticipant—
DateCompanyRoundRaisedValuationRoleEvidence
Apr 24, 2024Xaira TherapeuticsSeries A (stealth launch / incubated by co-leads)$1B—Participant
Source ↗
UndatedOwkinSeries B (total disclosed by Owkin)$230M—Participant
Source ↗
DateCompanyRoundRaisedValuationRoleEvidence
Apr 24, 2024Xaira TherapeuticsSeries A (stealth launch / incubated by co-leads)$1B—Participant
Source ↗
UndatedOwkinSeries B (total disclosed by Owkin)$230M—Participant
Source ↗